List of Excipients in API colestipol hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing colestipol hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pharmacia & Upjohn Company LLC | COLESTID | colestipol hydrochloride | 0009-0260 | SILICON DIOXIDE | |
| Pharmacia & Upjohn Company LLC | COLESTID | colestipol hydrochloride | 0009-0450 | CARNAUBA WAX | |
| Pharmacia & Upjohn Company LLC | COLESTID | colestipol hydrochloride | 0009-0450 | HYPROMELLOSE | |
| Pharmacia & Upjohn Company LLC | COLESTID | colestipol hydrochloride | 0009-0450 | MAGNESIUM STEARATE | |
| Pharmacia & Upjohn Company LLC | COLESTID | colestipol hydrochloride | 0009-0450 | POVIDONE | |
| Pharmacia & Upjohn Company LLC | COLESTID | colestipol hydrochloride | 0009-0450 | SILICON DIOXIDE | |
| Pharmacia & Upjohn Company LLC | COLESTID | colestipol hydrochloride | 0009-0450 | TRIACETIN | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing colestipol hydrochloride
Detailed excipient profiles for colestipol hydrochloride
Excipient focus: CARNAUBA WAX
colestipol hydrochloride drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | colestipol hydrochloride | 0009-0450 |
| Physicians Total Care Inc | colestipol hydrochloride | 54868-0610 |
| Greenstone LLC | colestipol hydrochloride | 59762-0450 |
| Carilion Materials Management | colestipol hydrochloride | 68151-4361 |
| >Company | >Ingredient | >NDC |
colestipol hydrochloride drug variants not containing CARNAUBA WAX
Excipient focus: CELLACEFATE
colestipol hydrochloride drug variants containing CELLACEFATE
colestipol hydrochloride drug variants not containing CELLACEFATE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
colestipol hydrochloride drug variants containing CELLULOSE, MICROCRYSTALLINE
colestipol hydrochloride drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: COPOVIDONE
colestipol hydrochloride drug variants containing COPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | colestipol hydrochloride | 42799-115 |
| >Company | >Ingredient | >NDC |
colestipol hydrochloride drug variants not containing COPOVIDONE
Excipient focus: COPOVIDONE K25-31
colestipol hydrochloride drug variants containing COPOVIDONE K25-31
colestipol hydrochloride drug variants not containing COPOVIDONE K25-31
Excipient focus: CROSPOVIDONE
colestipol hydrochloride drug variants containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | colestipol hydrochloride | 70710-1467 |
| Zydus Lifesciences Limited | colestipol hydrochloride | 70771-1653 |
| >Company | >Ingredient | >NDC |
colestipol hydrochloride drug variants not containing CROSPOVIDONE
Excipient focus: DIBUTYL SEBACATE
colestipol hydrochloride drug variants containing DIBUTYL SEBACATE
colestipol hydrochloride drug variants not containing DIBUTYL SEBACATE
Excipient focus: FERRIC OXIDE YELLOW
colestipol hydrochloride drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | colestipol hydrochloride | 70710-1467 |
| Zydus Lifesciences Limited | colestipol hydrochloride | 70771-1653 |
| >Company | >Ingredient | >NDC |
colestipol hydrochloride drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: HYPROMELLOSE
colestipol hydrochloride drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pharmacia & Upjohn Company LLC | colestipol hydrochloride | 0009-0450 |
| Greenstone LLC | colestipol hydrochloride | 59762-0450 |
| >Company | >Ingredient | >NDC |
colestipol hydrochloride drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
colestipol hydrochloride drug variants containing HYPROMELLOSE 2910
colestipol hydrochloride drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
colestipol hydrochloride drug variants containing HYPROMELLOSES
colestipol hydrochloride drug variants not containing HYPROMELLOSES
Excipient focus: MAGNESIUM STEARATE
colestipol hydrochloride drug variants containing MAGNESIUM STEARATE
colestipol hydrochloride drug variants not containing MAGNESIUM STEARATE
Excipient focus: MICROCRYSTALLINE CELLULOSE 105
colestipol hydrochloride drug variants containing MICROCRYSTALLINE CELLULOSE 105
| Company | Ingredient | NDC |
|---|---|---|
| Bora Pharmaceuticals Laboratories Inc | colestipol hydrochloride | 43826-027 |
| ANI Pharmaceuticals Inc | colestipol hydrochloride | 62559-395 |
| >Company | >Ingredient | >NDC |
colestipol hydrochloride drug variants not containing MICROCRYSTALLINE CELLULOSE 105
Excipient focus: POLYETHYLENE GLYCOL 6000
colestipol hydrochloride drug variants containing POLYETHYLENE GLYCOL 6000
colestipol hydrochloride drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYVINYL ALCOHOL
colestipol hydrochloride drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals USA Inc | colestipol hydrochloride | 70710-1467 |
| Zydus Lifesciences Limited | colestipol hydrochloride | 70771-1653 |
| >Company | >Ingredient | >NDC |
colestipol hydrochloride drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POVIDONE
colestipol hydrochloride drug variants containing POVIDONE
colestipol hydrochloride drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
colestipol hydrochloride drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Bora Pharmaceuticals Laboratories Inc | colestipol hydrochloride | 43826-027 |
| ANI Pharmaceuticals Inc | colestipol hydrochloride | 62559-395 |
| >Company | >Ingredient | >NDC |
colestipol hydrochloride drug variants not containing POVIDONE K30
Excipient focus: POVIDONES
colestipol hydrochloride drug variants containing POVIDONES
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | colestipol hydrochloride | 68151-4361 |
| >Company | >Ingredient | >NDC |
colestipol hydrochloride drug variants not containing POVIDONES
Excipient focus: SILICON DIOXIDE
colestipol hydrochloride drug variants containing SILICON DIOXIDE
colestipol hydrochloride drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
colestipol hydrochloride drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Edenbridge Pharmaceuticals LLC | colestipol hydrochloride | 42799-115 |
| >Company | >Ingredient | >NDC |
colestipol hydrochloride drug variants not containing TALC
Excipient focus: TRIACETIN
colestipol hydrochloride drug variants containing TRIACETIN
colestipol hydrochloride drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
